161 related articles for article (PubMed ID: 25201577)
1. Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer.
Jin H; Liang Y; Wang X; Zhu J; Sun R; Chen P; Nie X; Gao L; Zhang L
Med Oncol; 2014 Oct; 31(10):221. PubMed ID: 25201577
[TBL] [Abstract][Full Text] [Related]
2. A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.
Li ZH; Pan XM; Han BW; Guo XM; Zhang Z; Jia J; Gao LB
Tumour Biol; 2013 Oct; 34(5):3159-63. PubMed ID: 23729275
[TBL] [Abstract][Full Text] [Related]
3. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk.
Pan XM; Sun RF; Li ZH; Guo XM; Zhang Z; Qin HJ; Xu GH; Gao LB
Tumour Biol; 2014 Jan; 35(1):831-5. PubMed ID: 23975373
[TBL] [Abstract][Full Text] [Related]
4. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma.
Pan XM; Jia J; Guo XM; Li ZH; Zhang Z; Qin HJ; Xu GH; Gao LB
Fam Cancer; 2014 Mar; 13(1):93-7. PubMed ID: 23996697
[TBL] [Abstract][Full Text] [Related]
6. A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation.
Liu A; Zhang W; Zhao T; Xiao M; Mei Q; Zhu H
J Cell Physiol; 2019 Dec; 234(12):23437-23447. PubMed ID: 31152438
[TBL] [Abstract][Full Text] [Related]
7. Association analysis between the interaction of RAS family genes mutations and papillary thyroid carcinoma in the Han Chinese population.
Jin M; Li Z; Sun Y; Zhang M; Chen X; Zhao H; Yu Q
Int J Med Sci; 2021; 18(2):441-447. PubMed ID: 33390813
[TBL] [Abstract][Full Text] [Related]
8. A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.
Liang Y; Sun R; Li L; Yuan F; Liang W; Wang L; Nie X; Chen P; Zhang L; Gao L
Medicine (Baltimore); 2015 Aug; 94(31):e1289. PubMed ID: 26252302
[TBL] [Abstract][Full Text] [Related]
9. Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases.
Kim M; Chen X; Chin LJ; Paranjape T; Speed WC; Kidd KK; Zhao H; Weidhaas JB; Slack FJ
Cell Cycle; 2014; 13(6):1030-40. PubMed ID: 24552817
[TBL] [Abstract][Full Text] [Related]
10. Association Between Genetic Polymorphisms in the Promoter Regions of Let-7 and Risk of Papillary Thyroid Carcinoma: A Case-Control Study.
Wang Y; Wei T; Xiong J; Chen P; Wang X; Zhang L; Gao L; Zhu J
Medicine (Baltimore); 2015 Oct; 94(43):e1879. PubMed ID: 26512603
[TBL] [Abstract][Full Text] [Related]
11. A subset of papillary thyroid carcinomas contain KRAS mutant subpopulations at levels above normal thyroid.
Myers MB; McKim KL; Parsons BL
Mol Carcinog; 2014 Feb; 53(2):159-67. PubMed ID: 22930660
[TBL] [Abstract][Full Text] [Related]
12. An let-7 KRAS rs712 polymorphism increases hepatocellular carcinoma risk.
Xiong D; Song YP; Xiong W; Liang YD
Genet Mol Res; 2015 Oct; 14(4):14050-5. PubMed ID: 26535719
[TBL] [Abstract][Full Text] [Related]
13. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
Dong G; Zhang R; Xu J; Guo Y
Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
[TBL] [Abstract][Full Text] [Related]
14. Association of rs712 polymorphism in Kras gene 3'-luntranslated region and cancer risk: a meta-analysis.
Zhao WH; Qu XF; Xing ZG; Zhao LQ; Qin L; Lv C
J BUON; 2015; 20(1):309-16. PubMed ID: 25778332
[TBL] [Abstract][Full Text] [Related]
15. Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma.
Wang WY; Chien YC; Wong YK; Lin YL; Lin JC
Head Neck; 2012 May; 34(5):663-6. PubMed ID: 21688344
[TBL] [Abstract][Full Text] [Related]
16. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.
Zou M; Baitei EY; Alzahrani AS; BinHumaid FS; Alkhafaji D; Al-Rijjal RA; Meyer BF; Shi Y
Thyroid; 2014 Aug; 24(8):1256-66. PubMed ID: 24798740
[TBL] [Abstract][Full Text] [Related]
17. Association between the
Ning L; Rao W; Yu Y; Liu X; Pan Y; Ma Y; Liu R; Zhang S; Sun H; Yu Q
J Cancer; 2016; 7(15):2420-2426. PubMed ID: 27994680
[TBL] [Abstract][Full Text] [Related]
18. A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers.
Christensen BC; Moyer BJ; Avissar M; Ouellet LG; Plaza SL; McClean MD; Marsit CJ; Kelsey KT
Carcinogenesis; 2009 Jun; 30(6):1003-7. PubMed ID: 19380522
[TBL] [Abstract][Full Text] [Related]
19. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.
Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731
[TBL] [Abstract][Full Text] [Related]
20. Significant association between Let-7-KRAS rs712 G > T polymorphism and cancer risk in the Chinese population: a meta-analysis.
Du XY; Hu YY; Xie C; Deng CY; Liu CY; Luo ZG; Niu YM; Shen M
Oncotarget; 2017 Feb; 8(8):13863-13871. PubMed ID: 28099923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]